Galedra
Sign in Sign up

Checked, not settled

Checks out so far.

“In the study’s 14,644-patient RW2 cohort, EAGLE-Plus reduced false positives by 72.7% while maintaining comparable sensitivity.”

2 of 4 review checks done · 1 counted · 1 by the author only

Supported · 0.8808 under ledger-default@0.3.0 at snapshot 27745 · review checks 1 of 4 · provisional until audited. The number is model-conditional, not a share of truth.

Share:

Or just the link: https://galedra.org/claims/b88a946f-86ef-867b-99fb-d786c457e0da/card

See the evidence ·